Physician profile
Sarah E Shim
NPI 1598070955
$3,561.18
in general payments reported to CMS, 2019-2025
17 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $301 · 2021: $503 · 2022: $483 · 2023: $548 · 2024: $429 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $792.30 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Johnson & Johnson Vision Care, INC. | $623.09 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $587.06 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $457.16 | 2019-2021 | |
| Coopervision INC. | $282.16 | 2019 | |
| Sun Pharmaceutical Industries INC. | $185.55 | 2021-2024 | Cequa |
| Allergan, INC. | $109.98 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $97.76 | 2021 | |
| Optos, INC. | $91.30 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $79.30 | 2019-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $62.27 | 2019 | |
| Abbvie INC. | $60.46 | 2022-2025 | |
| Harrow Eye, LLC | $46.63 | 2024-2025 | Vevye |
| Oyster Point Pharma, INC. | $35.55 | 2022-2025 | Tyrvaya |
| Dompe US, INC. | $22.01 | 2024 | Oxervate |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $14.65 | 2024 | Cirrus Hd-Oct |
| Oasis Medical, INC. | $13.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Shim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.